An overview of common medical comorbidities in patients with schizophrenia

Journal of Clinical Psychiatry

Volumn 66, Issue SUPPL. 6, 2005, Pages 3-4

  Nasrallah, Henry A ^a,b  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF CINCINNATI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLOZAPINE; NEUROLEPTIC AGENT;

CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; COGNITIVE DEFECT; COMORBIDITY; DIABETES MELLITUS; EDITORIAL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; METABOLIC DISORDER; MYOCARDITIS; NEUROLOGIC DISEASE; ORTHOSTATIC HYPOTENSION; PRIORITY JOURNAL; SCHIZOPHRENIA; SUBSTANCE ABUSE;

COMORBIDITY; HUMANS; SCHIZOPHRENIA;

EID: 24144458244     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (5)

1. Sokal J, Messias E, Dickerson FB, et al. Comorbidity of medical illnesses among adults with serious mental illness who are receiving community psychiatric services. J Nerv Ment Dis 2004;192:421-427
2. Green AI, Canuso CM, Brenner MJ, et al. Detection and management of comorbidity in patients with schizophrenia. Psychiatr Clin North Am 2003;26:115-139
3. Marder SR. Evidence of using atypical antipsychotics in psychosis. Prim Care Companion J Clin Psychiatry 2003;5(suppl 3):22-26
4. Mokdad AH, Marks JS, Stroup DF, et al. Actual causes of death in the United States, 2000. JAMA 2004;291: 1238-1245
5. Minino AM, Arias E, Kochanek KD, et al. Deaths: final data for 2000. Natl Vital Stat Rep 2002;50:1-119